The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)Kremlin: It is very important to ensure the safety of our bases and diplomatic missions.Wanfang Development: A supplementary agreement on equity transfer of RMB 12.3 million was signed, and Wanfang Development announced that the company held the 66th meeting of the 9th Board of Directors on December 11th, 2024, at which the Proposal on the Progress of Selling a wholly-owned subsidiary and Signing a Supplementary Agreement was reviewed and approved. The Company signed Supplementary Agreement III to the Equity Transfer Agreement with Beijing Tianyuan and Beijing Baiyu, and Beijing Baiyu will pay the remaining equity transfer amount of RMB 12.3 million to the Company before December 31, 2025. As of the disclosure date of the announcement, Beijing Baiyu has paid 77.7 million yuan of equity transfer to the company, and the remaining 12.3 million yuan of equity transfer has not been paid. The company has transferred its 86.3333% equity of Beijing Tianyuan to Beijing Baiyu, so far, the company holds 13.6667% equity of Beijing Tianyuan.
India's NIFTY metal index rose by 1.25%.Spot gold just broke through the $2,690.00/oz mark, and the latest price was $2,689.72/oz, down 0.15% in the day.Pakistan KSE-100 index rose 0.5% to 109,693.20.
ADB approved a loan of US$ 200 million for power infrastructure construction in Pakistan.Albertson terminated its merger with krogh and announced an increase in dividend and repurchase plan. albertson Company announced that it had exercised its right to terminate its merger agreement with krogh, because the US District Court in Oregon and the District Court in Washington issued an injunction on the proposed merger on December 10th. Vivek Sankaran, CEO of the company, commented: "In view of the recent decision of the federal and state courts to block the proposed merger between the company and krogh, we have made a difficult decision to terminate the merger agreement. We are very disappointed with the court's decision. " In addition, the board of directors of albertson Company plans to increase the quarterly cash dividend from $0.12 to $0.15 per share, and approved a stock repurchase plan of up to $2 billion.Southbound funds bought a net of 7.285 billion yuan today, and southbound funds bought a net of 7.285 billion yuan today. In terms of Hong Kong Stock Connect (Shanghai), TraHK and China Mobile received net purchases of HK$ 2.719 billion and HK$ 352 million respectively; Tencent Holdings ranked first in net sales, amounting to HK$ 491 million; In terms of Hong Kong Stock Connect (Shenzhen Stock Connect), TraHK and Hang Seng China Enterprises received net purchases of HK$ 2.501 billion and HK$ 665 million respectively; Meituan -W ranked first in net sales, amounting to HK$ 602 million.
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
12-14